Ribavirin/sofosbuvirLack of efficacy: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1833卷 / 1期

关键词：

D O I：

10.1007/s40278-020-87155-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：337 / 337

相关论文

共 50 条

[1] Daclatasvir/ribavirin/sofosbuvirLack of efficacy: case report
Reactions Weekly, 2023, 1950 (1) : 148 - 148
[2] Ribavirin/rituximab/sofosbuvirLack of efficacy and drug intolerance
Reactions Weekly, 2024, 2015 (1) : 377 - 377
[3] Daclatasvir/sofosbuvirLack of efficacy following off label use: 2 case reports
Reactions Weekly, 2022, 1911 (1) : 165 - 165
[4] Daclatasvir/sofosbuvirLack of efficacy: case report
Reactions Weekly, 2020, 1834 (1) : 93 - 93
[5] Ledipasvir/sofosbuvirLack of efficacy: case report
Reactions Weekly, 2022, 1923 (1) : 278 - 278
[6] Ledipasvir/sofosbuvirLack of efficacy: case report
Reactions Weekly, 2023, 1959 (1) : 362 - 362
[7] Ribavirin/sofosbuvirLactic acidosis: 5 case reports
Reactions Weekly, 2016, 1601 (1) : 207 - 207
[8] Ribavirin/sofosbuvirVarious toxicities: 5 case reports
Reactions Weekly, 2020, 1794 (1) : 203 - 203
[9] Ribavirin/sofosbuvirVarious toxicities: 5 case reports
Reactions Weekly, 2018, 1730 (1) : 265 - 265
[10] Ribavirin/sofosbuvir/velpatasvirLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1953 (1) : 355 - 355

← 1 2 3 4 5 →